Detalhe da pesquisa
1.
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
Cancer
; 129(11): 1723-1734, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869646
2.
Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma.
Oncologist
; 28(3): 220-229, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36562592
3.
De novo HRAS gene mutation associated with Costello syndrome identified by non-invasive cell-free fetal DNA screening.
Prenat Diagn
; 41(1): 11-14, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681669
4.
Correlation between variant allele frequency and mean tumor molecules with tumor burden in patients with solid tumors.
Mol Oncol
; 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037739
5.
Treatment Response Monitoring Using a Tumor-Informed Circulating Tumor DNA Test in an Advanced Triple-Negative Breast Cancer Patient: A Case Report.
Case Rep Oncol
; 15(2): 473-479, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702676
6.
Post-operative ctDNA monitoring in stage I colon cancer: A case report.
Front Oncol
; 12: 1074786, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36591529
7.
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.
JCO Precis Oncol
; 6: e2200420, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480779
8.
BESPOKE study protocol: a multicentre, prospective observational study to evaluate the impact of circulating tumour DNA guided therapy on patients with colorectal cancer.
BMJ Open
; 11(9): e047831, 2021 09 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561256
9.
Genetics objective structured clinical exams at the Maimonides Infants & Children's Hospital of Brooklyn, New York.
Acad Med
; 83(11): 1088-93, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18971664